Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Quinolones].

H Lode1

  • 1Medizinische Klinik, Klinikum Steglitz, Freien Universität Berlin.

Schweizerische Medizinische Wochenschrift
|December 10, 1988
PubMed
Summary
This summary is machine-generated.

New quinolones offer potent antibacterial activity, particularly against gram-negative pathogens, with favorable pharmacokinetics for oral administration. Reserve these advanced antibiotics for complex infections, monitoring for central nervous system side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Indications for the monitoring of aminoglycoside serum concentrations in internal medicine].

Infection·2016
Same author

Per Migliorare la Guarigione di Pazienti Affetti da Infezione del Tratto Respiratorio.

Journal of chemotherapy (Florence, Italy)·2016
Same author

[Progress with management of hereditary angioedema].

MMW Fortschritte der Medizin·2013
Same author

[Is monotherapy with β-lactam antibiotics still up to date? New aspects for treatment of severe infections].

Deutsche medizinische Wochenschrift (1946)·2012
Same author

Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 ×, 2 ×, or 4 ×) in healthy subjects aged 70 years or older.

Vaccine·2011
Same author

Radiolabeled metaiodobenzylguanidine (mibg) in diagnosis and therapy of neuroblastoma - results from basic research (review).

International journal of oncology·2011
Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010
Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010
Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010
Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010
Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010
Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010
See all related articles

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Context:

  • Emerging quinolone antibiotics demonstrate significant antibacterial efficacy.
  • These agents possess favorable pharmacokinetic profiles, including oral bioavailability and prolonged elimination.
  • Quinolones are comparable to beta-lactams and aminoglycosides in treating challenging infections.

Purpose:

  • To evaluate the therapeutic potential and optimal application of new quinolone antibiotics.
  • To compare the efficacy and pharmacokinetics of newer quinolones with established antibiotic classes.
  • To provide guidance on the judicious use of quinolones in clinical practice.

Summary:

  • New quinolones exhibit high antibacterial activity against gram-negative pathogens.

Related Experiment Videos

  • Their pharmacokinetic properties, such as oral absorption and long half-life, are advantageous.
  • These antibiotics are effective for complicated infections of the respiratory, intestinal, urinary tracts, and bones.
  • Careful consideration of central nervous system (CNS) intolerance is crucial.

    • Impact:

    • New quinolones represent a therapeutic advancement, especially for infections caused by problematic organisms like Pseudomonas aeruginosa.
    • Restrictive and critical use is advised, reserving them for complicated infections where other options are limited.
    • Understanding and managing CNS side effects is essential for safe and effective quinolone therapy.